1. Penicillin And Streptomycin Market – Overview
1.1 Definitions and Scope
2. Penicillin And Streptomycin Market- Executive Summary
2.1 Market Revenue, Market Size & Key Trends
2.2 Key trends by Application
2.3 Key trends by Product type
2.4 Key trends by Manufacturing process
2.5 Key trends by Route of Administration
2.6 Key trends by End User
2.7 Key trends by Geography
3. Penicillin And Streptomycin Market– Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Penicillin And Streptomycin Market – Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Penicillin And Streptomycin Market– Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Penicillin And Streptomycin Market– By Application (Market Size – $Million/$Billion)
6.1 Throat Infections
6.2 Meningitis
6.3 Tuberculosis
6.4 Others.
7. Penicillin And Streptomycin Market– By Product Type (Market Size – $Million/$Billion)
7.1 Penicillin
7.2 Streptomycin
8. Penicillin And Streptomycin Market– By Manufacturing Process (Market Size – $Million/$Billion)
8.1 Penicillin
8.1.1 Natural
8.1.2 Synthetic
8.1.3 Semi-Synthetic
8.2 Streptomycin
8.2.1 Natural
8.2.2 Synthetic
8.2.3 Semi-Synthetic
9. Penicillin And Streptomycin Market– By Route of Administration (Market Size – $Million/$Billion)
9.1 Oral
9.2 Intramuscular
9.3 Intravenous
10. Penicillin And Streptomycin Market– By End User (Market Size – $Million/$Billion)
10.1 Hospital
10.2 Clinics
10.3 Others(Clinical laboratories)
11. Penicillin And Streptomycin Market- By Geography (Market Size – $Million/$Billion)
11.1 North America
11.1.1 U.S.
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 U.K.
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia-Pacific
11.3.1 China
11.3.2 India
11.3.3 Japan
11.3.4 South Korea
11.3.5 Australia & New Zealand
11.3.6 Rest of Asia-Pacific
11.4 Rest of the World
11.4.1 Middle East
11.4.2 Africa
11.4.3 South America
12. Penicillin And Streptomycin Market – Entropy
13. Penicillin And Streptomycin Market Company Analysis
13.1 Pfizer, Inc
13.2 GlaxoSmithKline Plc
13.3 Johnson & Johnson
13.4 Lonza AG
13.5 Novartis Healthcare
13.6 Merck & Co
13.7 Dr Reddy Laboratories
13.8 Takeda Pharmaceutical Company Ltd
13.9 Astellas Pharma Inc
13.10 Eli Lilly and company
“*Financials for private companies would be provided on a best efforts basis”.
IndustryARC
I 기본 3,500,000원부터~
Report Description
Overview
페니실린과 스트렙토마이신은 주요 항생제로, 감염성 질환의 치료에 널리 사용됩니다. 특히 목 감염, 결핵, 수막염 등 다양한 질병의 치료에 중요한 역할을 합니다.
Segment
제품은 페니실린과 스트렙토마이신으로 나뉘며, 제조 방식은 천연, 합성, 반합성으로 구분됩니다. 경구, 근육 주사, 정맥 주사를 포함한 투여 경로와 병원, 클리닉 등의 최종 사용자가 포함됩니다.
Key Takeaways
감염성 질환 증가와 항생제 기술의 발전이 시장을 주도하고 있습니다. 특히, 저비용 제조 공정의 개발과 신흥 시장에서의 높은 수요가 중요한 성장 요인입니다.